Psychedelics Funding At Its Best: $1.5M Destined To Psilocin Clinical Trials In Australia
Psychedelics biopharma company Lobe Sciences Ltd.
Nasdaq-listed Bright Minds Closes $4 Million Offering And Begins Dosing In Clinical Trial For Epilepsy
Biopharma company developing next-generation mental health treatments Bright Minds Biosciences Inc. (NASDAQ: DRUG) has closed its overnight offering for gross proceeds of approximately $4 million.
Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Nuwellis, Inc. (NASDAQ: NUWE) shares jumped 140% to $1.5894 after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in high-risk postoperative coronary artery bypass grafting patients.
Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday
Gainers
Mobile Global Esports Inc. (NASDAQ: MGAM) shares surged 103.9% to settle at $5.30 on Tuesday. Shares are in low-float territory; the issue has about 15 million shares in its float.
Why Hill International Is Trading Higher By 15%; Here Are 30 Stocks Moving Premarket
Gainers
NewAge, Inc. (NASDAQ: NBEV) shares rose 19.7% to $0.2432 in pre-market trading. NewAge recently received Nasdaq notice on late filing of its form 10-Q.
Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday
Gainers
Micro Focus International plc (NYSE: MFGP) shares surged 92% to close at $6.01 on Friday after the company reached an agreement with OpenText to be acquired for $6 billion.
Why Farfetch Is Trading Higher By 32%, Here Are 46 Stocks Moving In Friday’s Mid-Day Session
Gainers
Micro Focus International plc (NYSE: MFGP) shares jumped 95.4% to $6.11 after the company reached an agreement with OpenText to be acquired for $6 billion.